Strategic Workshops Supporting Pharma’s Future

How to deliver the degree of holistic and objective understanding that today’s market demands

For any company seeking success, strategic intelligence is crucial.

For the pharma industry, the questions surrounding how to win have become increasingly complex, and the answers even more so. Distilling and prioritising the information crucial to strategy-formation can appear a labrynthine task.

So how do you deliver the degree of holistic – and objective – understanding that today’s circuitous market demands? Should you challenge your existing business model? And how can you prepare for the next disruption?

Breakthrough thinking, we’ve seen, lies in the prioritization of a full Strategic Preparedness Workshop (SPW). The SPW goes far beyond traditional pharma workshops that assess one or a few competitors or helps to clarify the path to an already clear-cut goal. Instead, SPWs align key stakeholders early in the direction setting process via a thorough exploration of the strategic challenges, disruptors, and opportunities facing a company. SPWs give leaders a chance to align, engage, and explore the best strategic approach based on deep knowledge of external as well as internal success factors.

In this paper, we’ll show how SPWs should be run – and why.

DOWNLOAD WHITE PAPER

You may also be interested in…

A message from our Chairwoman

At Deallus we are fortunate to have Ulrike Meier as our Chairwoman since 2020. Ulrike has written a brilliant blog reflecting on her time with Deallus so far and shares some insights into, even if removed from daily business, as Chairwoman, there is room to make a difference. From being authentic, focusing on the bigger picture, to providing motivation and guidance, Ulrike explores what key elements she prioritises in her role and how we can all play a part in organisation success.

World Immunization Week 2024

Decades of transformation, fueled by unprecedented innovation are continuously pushing the bar for what the vaccines industry needs to deliver. A tight balance of public and global health commitments, and commercial attractiveness.

Unlocking Insights at PharmaCI: A Recap from Deallus

At Deallus, we constantly strive to immerse ourselves in the latest developments and conversations within the competitive intelligence (CI) landscape. Recently, we had the privilege of attending PharmaCI in Munich, where we engaged in enriching discussions with esteemed clients, peers, and colleagues.

  • AI in pharma

Can AI really help you understand what matters in your market?

The impact of AI across our industry will be profound. It’s already driving faster identification of novel drug targets and drug discovery, better patient identification, accelerated drug development, earlier diagnosis, and more personalized healthcare.